Synthetic Lethal Interactions in Cancer Therapy.

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Synthetic lethality occurs when simultaneous silencing of two or more complementary signaling pathways induces cell death.
• Loss of a single genetic function typically does not result in a severe phenotype, highlighting the specific nature of synthetic lethal interactions.

Purpose of the Study:

• To review and summarize the synthetic lethal interactions that have been exploited in anticancer therapies.
• To provide an overview of established synthetic lethality strategies in cancer treatment prior to 2016.

Main Methods:

• Literature review of scientific publications and clinical studies.
• Analysis of synthetic lethal interactions reported in anticancer therapies up to 2016.

Main Results:

• Synthetic lethality is a validated and effective strategy in cancer therapy.
• Multiple synthetic lethal interactions have been identified and are being translated into clinical applications.

Conclusions:

• Synthetic lethality represents a significant advancement in cancer treatment.
• The ongoing translation of synthetic lethal interactions into clinical cancer therapies underscores its therapeutic potential.